Erythropoietin?(EPO) is a hormone produced by the kidney that promotes the formation of red blood cells by the bone marrow.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Erythropoietin (EPO) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Market Segment by Product Application
Anemia
Kidney Disorders
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Erythropoietin (EPO) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Erythropoietin (EPO) market by identifying its various subsegments.
3.Focuses on the key global Erythropoietin (EPO) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Erythropoietin (EPO) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Erythropoietin (EPO) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Erythropoietin (EPO) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Erythropoietin (EPO) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Erythropoietin (EPO) Segment by Type
2.1.1 Epoetin-alfa
2.1.2 Darbepoetin-alfa
2.1.3 Epoetin-beta
2.1.4 Others
2.2 Market Analysis by Application
2.2.1 Anemia
2.2.2 Kidney Disorders
2.2.3 Other
2.3 Global Erythropoietin (EPO) Market Comparison by Regions (2017-2027)
2.3.1 Global Erythropoietin (EPO) Market Size (2017-2027)
2.3.2 North America Erythropoietin (EPO) Status and Prospect (2017-2027)
2.3.3 Europe Erythropoietin (EPO) Status and Prospect (2017-2027)
2.3.4 China Erythropoietin (EPO) Status and Prospect (2017-2027)
2.3.5 Japan Erythropoietin (EPO) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Erythropoietin (EPO) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Erythropoietin (EPO) Industry Impact
2.5.1 Erythropoietin (EPO) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Erythropoietin (EPO) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Erythropoietin (EPO) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Erythropoietin (EPO) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Erythropoietin (EPO) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Erythropoietin (EPO) Manufacturer Market Share
3.5 Top 10 Erythropoietin (EPO) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Erythropoietin (EPO) Market
3.7 Key Manufacturers Erythropoietin (EPO) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Erythropoietin (EPO) Industry Key Manufacturers
4.1 Amgen
4.1.1 Compan Detail
4.1.2 Amgen Erythropoietin (EPO) Product Introduction, Application and Specification
4.1.3 Amgen 131 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 Johnson & Johnson
4.2.1 Compan Detail
4.2.2 Johnson & Johnson Erythropoietin (EPO) Product Introduction, Application and Specification
4.2.3 Johnson & Johnson Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Amgen News
4.3 Roche
4.3.1 Compan Detail
4.3.2 Roche Erythropoietin (EPO) Product Introduction, Application and Specification
4.3.3 Roche Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Roche News
4.4 Galenica
4.4.1 Compan Detail
4.4.2 Galenica Erythropoietin (EPO) Product Introduction, Application and Specification
4.4.3 Galenica Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Galenica News
4.5 Emcure
4.5.1 Compan Detail
4.5.2 Galenica Erythropoietin (EPO) Product Introduction, Application and Specification
4.5.3 Emcure Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Emcure News
4.6 Kyowa Hakko Kirin
4.6.1 Compan Detail
4.6.2 Kyowa Hakko Kirin Erythropoietin (EPO) Product Introduction, Application and Specification
4.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Kyowa Hakko Kirin News
4.7 3SBio
4.7.1 Compan Detail
4.7.2 3SBio Erythropoietin (EPO) Product Introduction, Application and Specification
4.7.3 3SBio Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Biocon
4.8.1 Compan Detail
4.8.2 Biocon Erythropoietin (EPO) Product Introduction, Application and Specification
4.8.3 Biocon Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Biocon News
4.9 LG Life Sciences
4.9.1 Compan Detail
4.9.2 LG Life Sciences Erythropoietin (EPO) Product Introduction, Application and Specification
4.9.3 LG Life Sciences Erythropoietin (EPO) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 LG Life Sciences News
5 Global Erythropoietin (EPO) Market Segment by Big Type
5.1 Global Erythropoietin (EPO) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Erythropoietin (EPO) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Erythropoietin (EPO) Revenue and Market Share by Big Type (2017-2022)
5.2 Epoetin-alfa Sales Growth Rate and Price
5.2.1 Global Epoetin-alfa Sales Growth Rate (2017-2022)
5.2.2 Global Epoetin-alfa Price (2017-2022)
5.3 Darbepoetin-alfa Sales Growth Rate and Price
5.3.1 Global Darbepoetin-alfa Sales Growth Rate (2017-2022)
5.3.2 Global Darbepoetin-alfa Price (2017-2022)
5.4 Epoetin-beta Sales Growth Rate and Price
5.4.1 Global Epoetin-beta Sales Growth Rate (2017-2022)
5.4.2 Global Epoetin-beta Price (2017-2022)
5.5 Others Sales Growth Rate and Price
5.5.1 Global Others Sales Growth Rate (2017-2022)
5.5.2 Global Others Price (2017-2022)
6 Global Erythropoietin (EPO) Market Segment by Big Application
6.1 Global Erythropoietin (EPO) Sales Market Share by Big Application (2017-2022)
6.2 Anemia Sales Growth Rate (2017-2022)
6.3 Kidney Disorders Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Erythropoietin (EPO) Forecast
7.1 Global Erythropoietin (EPO) Revenue, Sales and Growth Rate (2022-2027)
7.2 Erythropoietin (EPO) Market Forecast by Regions (2022-2027)
7.2.1 North America Erythropoietin (EPO) Market Forecast (2022-2027)
7.2.2 Europe Erythropoietin (EPO) Market Forecast (2022-2027)
7.2.3 China Erythropoietin (EPO) Market Forecast (2022-2027)
7.2.4 Japan Erythropoietin (EPO) Market Forecast (2022-2027)
7.2.5 Southeast Asia Erythropoietin (EPO) Market Forecast (2022-2027)
7.2.6 Other Regions Erythropoietin (EPO) Market Forecast (2022-2027)
7.3 Erythropoietin (EPO) Market Forecast by Type (2022-2027)
7.3.1 Global Erythropoietin (EPO) Sales Forecast by Type (2022-2027)
7.3.2 Global Erythropoietin (EPO) Market Share Forecast by Type (2022-2027)
7.4 Erythropoietin (EPO) Market Forecast by Application (2022-2027)
7.4.1 Global Erythropoietin (EPO) Sales Forecast by Application (2022-2027)
7.4.2 Global Erythropoietin (EPO) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Erythropoietin (EPO) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Erythropoietin (EPO) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Erythropoietin (EPO)
Figure Market Concentration Ratio and Market Maturity Analysis of Erythropoietin (EPO)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Erythropoietin (EPO) Market Size by Big Type
Figure Global Market Share of Erythropoietin (EPO) by Big Type in 2021
Figure Epoetin-alfa Picture (2017-2022)
Figure Darbepoetin-alfa Picture (2017-2022)
Figure Epoetin-beta Picture (2017-2022)
Global Erythropoietin (EPO) Market Size by Big Application
Table Global Erythropoietin (EPO) Market Size by Application
Figure Global Erythropoietin (EPO) Market Share by Big Application in 2021
Figure Anemia Picture
Figure Kidney Disorders Picture
Figure Other Picture
Table Global Erythropoietin (EPO) Comparison by Regions (M USD) (2017-2027)
Figure Global Erythropoietin (EPO) Market Size (Million US$) (2017-2027)
Figure North America Erythropoietin (EPO) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Erythropoietin (EPO) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Erythropoietin (EPO) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Erythropoietin (EPO) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Erythropoietin (EPO) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Erythropoietin (EPO) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Erythropoietin (EPO) Sales by Manufacturer (2017-2022)
Figure Global Erythropoietin (EPO) Sales Market Share by Manufacturer in 2021
Table Global Erythropoietin (EPO) Revenue by Manufacturer (2017-2022)
Figure Global Erythropoietin (EPO) Revenue Market Share by Manufacturer in 2021
Table Global Erythropoietin (EPO) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Erythropoietin (EPO) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Erythropoietin (EPO) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Erythropoietin (EPO) Market
Table Key Manufacturers Erythropoietin (EPO) Product Type
Table Mergers & Acquisitions Planning
Table Amgen Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Amgen
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Johnson & Johnson Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Johnson & Johnson
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Recent Development
Table Roche Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Roche
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Galenica Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Galenica
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Galenica Main Business
Table Galenica Recent Development
Table Galenica Main Business
Table Galenica Recent Development
Table Emcure Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Emcure
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Emcure Main Business
Table Emcure Recent Development
Table Kyowa Hakko Kirin Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Kyowa Hakko Kirin
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kyowa Hakko Kirin Main Business
Table Kyowa Hakko Kirin Recent Development
Table 3SBio Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of 3SBio
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table 3SBio Main Business
Table 3SBio Recent Development
Table Biocon Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of Biocon
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biocon Main Business
Table Biocon Recent Development
Table LG Life Sciences Company Profile
Table Erythropoietin (EPO) Product Introduction, Application and Specification of LG Life Sciences
Table Erythropoietin (EPO) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table LG Life Sciences Main Business
Table LG Life Sciences Recent Development
Figure Global Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Figure Global Erythropoietin (EPO) Revenue and Growth Rate (2017-2022)
Table Global Erythropoietin (EPO) Sales by Regions (2017-2022)
Figure Global Erythropoietin (EPO) Sales Market Share by Regions in 2021
Table Global Erythropoietin (EPO) Revenue by Regions (2017-2022)
Figure Global Erythropoietin (EPO) Revenue Market Share by Regions in 2021
Figure North America Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Figure Europe Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Figure China Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Figure Japan Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Figure Other Regions Erythropoietin (EPO) Sales and Growth Rate (2017-2022)
Table Global Erythropoietin (EPO) Sales by Big Type (2017-2022)
Table Global Erythropoietin (EPO) Sales Market Share by Big Type (2017-2022)
Figure Global Erythropoietin (EPO) Sales Market Share by Big Type in 2019
Table Global Erythropoietin (EPO) Revenue by Big Type (2017-2022)
Table Global Erythropoietin (EPO) Revenue Market Share by Big Type (2017-2022)
Table Global Erythropoietin (EPO) Revenue Market Share by Big Type in 2019
Figure Global Epoetin-alfa Sales Growth Rate (2017-2022)
Figure Global Epoetin-alfa Price (2017-2022)
Figure Global Darbepoetin-alfa Sales Growth Rate (2017-2022)
Figure Global Darbepoetin-alfa Price (2017-2022)
Figure Global Epoetin-beta Sales Growth Rate (2017-2022)
Figure Global Epoetin-beta Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Erythropoietin (EPO) Sales by Big Application (2017-2022)
Table Global Erythropoietin (EPO) Sales Market Share by Big Application (2017-2022)
Figure Global Erythropoietin (EPO) Sales Market Share by Big Application in 2019
Figure Global Anemia Sales Growth Rate (2017-2022)
Figure Global Kidney Disorders Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Erythropoietin (EPO) Sales and Growth Rate (2022-2027)
Figure Global Erythropoietin (EPO) Revenue and Growth Rate (2022-2027)
Table Global Erythropoietin (EPO) Sales Forecast by Regions (2022-2027)
Table Global Erythropoietin (EPO) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Erythropoietin (EPO) Market Forecast (2022-2027)
Figure Europe Sales Erythropoietin (EPO) Market Forecast (2022-2027)
Figure China Sales Erythropoietin (EPO) Market Forecast (2022-2027)
Figure Japan Sales Erythropoietin (EPO) Market Forecast (2022-2027)
Figure Southeast Asia Sales Erythropoietin (EPO) Market Forecast (2022-2027)
Figure Other Regions Sales Erythropoietin (EPO) Market Forecast (2022-2027)
Table Global Erythropoietin (EPO) Sales Forecast by Type (2022-2027)
Table Global Erythropoietin (EPO) Market Share Forecast by Type (2022-2027)
Table Global Erythropoietin (EPO) Sales Forecast by Application (2022-2027)
Table Global Erythropoietin (EPO) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Erythropoietin (EPO)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Erythropoietin (EPO) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Erythropoietin (EPO) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Erythropoietin (EPO) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Erythropoietin (EPO) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Erythropoietin (EPO) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Erythropoietin (EPO) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Erythropoietin (EPO) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Erythropoietin (EPO) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio